© 2020 MJH Life Sciences and OncLive. All rights reserved.
July 1st 2020, 2:23am
The FDA has approved avelumab (Bavencio) for the maintenance treatment of patients with locally advanced or metastatic urothelial carcinoma that has not progressed with first-line platinum-based chemotherapy.
June 25th 2020, 6:50pm
Rana R. McKay, MD, discusses the design of the phase 3 PDIGREE study in advanced renal cell carcinoma.
June 25th 2020, 4:05pm
Félix Guerrero-Ramos, MD, PhD, FEBU, discusses the role of Bacillus Calmette-Guerin in the treatment of patients with non-muscle invasive bladder cancer.
June 25th 2020, 1:30pm
Scott S. Tykodi, MD, PhD, discusses the efficacy of dual checkpoint blockade in renal cell carcinoma.
June 24th 2020, 6:30pm
Investigators are using a novel clinical trial design to test multiple treatment strategies in an effort to define the standard of care in squamous cell carcinoma of the penis.
June 24th 2020, 2:20pm
Sumanta K. Pal, MD, discusses the background of the COSMIC-021 trial in urothelial cancer.
June 24th 2020, 2:15pm
Neeraj Agarwal, MD, discusses the rationale for novel combination therapies in metastatic castration-resistant prostate cancer.
June 23rd 2020, 4:13pm
In urothelial carcinoma models, enfortumab vedotin-ejfv appeared to promote multiple mechanisms of action such as bystander cell killing, supporting the use of the agent either alone or in combination with pembrolizumab.
June 23rd 2020, 2:40pm
Matthew Galsky, MD, discusses sequencing questions in urothelial carcinoma.
June 17th 2020, 10:16pm
Chung-Han Lee, MD, PhD, discusses the efficacy of combining immunotherapy with TKIs to treat patients with metastatic renal cell carcinoma.